Sanara MedTech (SMTI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
17 Apr, 2026Executive summary
Annual Meeting scheduled for June 4, 2026, at 10:00 A.M. CST, to be held virtually.
Shareholders are encouraged to review proxy materials and vote by June 3, 2026.
Materials include the Notice of Annual Meeting, Proxy Statement, and 2025 Annual Report.
Voting matters and shareholder proposals
Election of nine director nominees to serve until the 2027 Annual Meeting.
Ratification of Weaver and Tidwell, L.L.P. as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation for named executive officers.
Advisory vote on the frequency of future say-on-pay votes.
Proxy holders may vote on other business as may properly come before the meeting.
Board of directors and corporate governance
Nine director nominees are listed for election, with board recommendation to vote in favor.
Latest events from Sanara MedTech
- New Lead Independent Director and Compensation Committee chair appointed, with updated compensation.SMTI
Proxy filing17 Apr 2026 - Virtual annual meeting to vote on directors, auditor, executive pay, and governance matters.SMTI
Proxy filing17 Apr 2026 - Record 2025 revenue and margin, with 2026 growth outlook driven by surgical and market expansion.SMTI
Q4 202524 Mar 2026 - Pure-play surgical wound care focus, strong growth, and new product launches drive future outlook.SMTI
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - All agenda items, including director elections and governance changes, were approved.SMTI
AGM 20242 Feb 2026 - Q2 2024 revenue up 28% to $20.2M; gross margin 90%; net loss $3.5M; THP launch in 2025.SMTI
Q2 20241 Feb 2026 - Record Q3 revenue and EBITDA growth, but higher costs led to a larger net loss.SMTI
Q3 202414 Jan 2026 - Record Q3 revenue and strong growth reflect expanding adoption of advanced wound care platforms.SMTI
Piper Sandler 36th Annual Healthcare Conference11 Jan 2026 - Strong Q2 growth, leadership transition, and a promising product pipeline set the stage for expansion.SMTI
Cantor Global Healthcare Conference 202531 Dec 2025